Most Recent Articles about ASMB
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/412310/assembly-biosciences-asmb-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-412310 May 09, 2019 - Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 1.87% and 1.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/405102/analysts-estimate-assembly-biosciences-asmb-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-405102 Apr 29, 2019 - Assembly Biosciences (ASMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assembly Biosciences (ASMB) Reports Q3 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/336439/assembly-biosciences-asmb-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-336439 Nov 08, 2018 - Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 14.71% and 33.40%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Related Companies

Name Exchange Price Mkt Cap
RCKT Rocket Pharmaceuticals, Inc. NASDAQ $22.24 $882.06M
RVNC Revance Therapeutics, Inc. NASDAQ $23.5001 $868.04M
AMPH Amphastar Pharmaceuticals, Inc. NASDAQ $18.33 $847.88M
AMRN Amarin Corporation plc NASDAQ $2.83 $838.67M
CTMX CytomX Therapeutics, Inc. NASDAQ $18.52 $832.73M
Sector: Health Care > Industry: Major Pharmaceuticals